Accomplished healthcare executive Jim Glynn to lead home healthcare platform
For Immediate Release
Irvine, CA, April 15, 2016 – SV Life Sciences Advisers (“SVLS”) and Health Enterprise Partners (“HEP”) announced today that they have partnered with experienced healthcare services executive Jim Glynn to form Jet Health, Inc. (“Jet Health”). The new company will develop, acquire, and operate home health care companies as part of a strategy to build a leading national home health platform. SVLS, HEP and Mr. Glynn have committed significant equity capital to fund the growth of Jet Health.
Jim Glynn, Jet Health’s CEO, is a seasoned and highly accomplished home health care executive with deep expertise in building, acquiring, and growing home health care and home infusion businesses. Previously, Mr. Glynn served as CEO of Amerita, Inc., a private equity-backed specialty infusion platform. Mr. Glynn founded Amerita in 2006 and successfully grew the company to become the fifth largest specialty infusion provider in the U.S., with 18 locations generating $140 million in annualized revenue. Prior to his tenure at Amerita, Jim served in various senior management roles at Apria Healthcare, Gentiva Health Services, and Coram Healthcare. “At Amerita, Jim successfully built a health care services company that empowered local operators and clinicians to deliver high quality services in growing markets. We are excited to partner with Jim to replicate that model in home health care,” said Tom Flynn, Managing Partner at SVLS.
Home health care is a diversified industry comprised of skilled nursing care, physical, speech and occupational therapy, rehabilitative care, medical social services, personal care, and companion services. Jim stated, “The home health industry is poised to continue its strong recent growth driven by an aging U.S. population, patient preference to be treated in a comfortable and convenient setting at home, and significant cost savings relative to care in inpatient or nursing home facilities. I look forward to building Jet Health into a premier home health business in partnership with SVLS and HEP.” California-based Jet Health plans to leverage local brands and operating expertise while sharing best practices across its companies and centralizing traditional back office functions. Dave Tamburri, Partner at HEP, commenting on the critical role home health care plays in the post-acute care continuum, “Under Jim’s proven leadership, Jet Health will seek to partner with health systems and other providers to bring innovative approaches to post-acute care.”
About SV Life Sciences Advisers
SV Life Sciences Advisers, LLC (“SVLS”) is a global leader in healthcare and life sciences investing. SVLS affiliated funds have been investing in such companies since the early 1980s, forming its first dedicated healthcare fund in 1994. Today, SVLS manages five funds with approximately $2.0 billion of capital commitments under management. The firm has invested in over 175 companies through its venture funds, and employs a diversified investment strategy capitalizing on opportunities in the following subsectors; therapeutics, medical devices, healthcare information technology (HCIT) and healthcare services. SVLS employs a close symbiosis between operating and financial professionals which has led to significant success over five investment funds. SVLS has offices in Boston, London and San Francisco. For more information, please visit the company’s website at http://www.svlsa.com.
About Health Enterprise Partners
Health Enterprise Partners invests primarily in privately held, profitable, middle market companies in the health care information technology and health care service sectors. HEP’s strategy is to leverage its unique and extensive hospital system and health plan network, 26 members of which are investors in HEP’s funds. HEP seeks to invest in companies that improve the quality of the patient experience, reduce the cost of health care, and improve operating margins for their customers, typically hospital systems and / or health plans. For more information, please visit http://www.hepfund.com